Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/9822

Triethanolamine: Target Organs and Levels of Evidence for TR-518

Toxicology and Carcinogenesis Studies of Triethanolamine (CASRN 102-71-6) in B6C3F1 Mice (Dermal Studies)

Chemical (Study Title)
CASRN
Peer Review DateRoute/Exposure LevelsStudy Laboratory
Triethanolamine
102-71-6
05/22/2003Topical Application
MM: 0, 200, 630, OR 2000 MG/KG; FM: 0, 100, 300, OR 1000 MG/KG
Battelle Columbus Laboratory

Levels of Evidence

Male Mice: Equivocal Evidence
TypeOrgan/Tissue (Lesion)
May Have Been Related
  • Liver: HEMANGIOSARCOMA 1/50 0/50 6/50 1/50
Non-Neoplastic Lesions
  • LIVER: EOSINOPHILIC FOCUS
  • SKIN: (EPIDERMAL) HYPERPLASIA; SUPPURATIVE INFLAMMATION; ULCER; (DERMAL) CHRONIC INFLAMMATION
Female Mice: Some Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Liver: ADENOMA 9/50 18/50 20/50 33/50 COMBINED 12/50 23/50 24/50 34/50
Non-Neoplastic Lesions
  • LIVER: EOSINOPHILIC FOCUS
  • SKIN: (EPIDERMAL) HYPERPLASIA; SUPPURATIVE INFLAMMATION; ULCER; (DERMAL) CHRONIC INFLAMMATION